https://www.selleckchem.com/pr....oducts/pf-07265807.h
Serum IL-6 level tended to further spiked firstly and then decreased after TCZ therapy in 10 patients. A persistent and dramatic increase of IL-6 was observed in these four patients who failed treatment. TCZ appears to be an effective treatment option in COVID-19 patients with a risk of cytokine storms. And for these critically ill patients with elevated IL-6, the repeated dose of the TCZ is recommended. © 2020 Wiley Periodicals, Inc.BACKGROUND Gel properties are important in determining the quality of surimi. In addition to myofibr
Like
Comment
Share
